Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $92.9 Million - $108 Million
600,000 New
600,000 $103 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $22.9 Million - $25.8 Million
166,600 Added 27.77%
766,600 $119 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $59.6 Million - $74.2 Million
450,000 Added 300.0%
600,000 $80.8 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $21.7 Million - $25 Million
150,000 New
150,000 $23.9 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $132 Million - $151 Million
979,900 Added 279.97%
1,329,900 $178 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $43.4 Million - $55.2 Million
315,400 Added 911.56%
350,000 $53.6 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $72.7 Million - $82.5 Million
-683,400 Reduced 95.18%
34,600 $3.73 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $4.15 Million - $6.3 Million
-64,400 Reduced 8.23%
718,000 $54.7 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $31.9 Million - $39.9 Million
441,600 Added 129.58%
782,400 $69.3 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $12.3 Million - $14.8 Million
195,400 Added 134.39%
340,800 $25.8 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $8.13 Million - $10.4 Million
123,700 Added 570.05%
145,400 $10.6 Million
Q1 2019

May 08, 2019

BUY
$77.14 - $90.79 $1.6 Million - $1.88 Million
20,700 Added 2070.0%
21,700 $1.75 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $16.6 Million - $20.4 Million
-212,600 Reduced 99.53%
1,000 $92,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $7.8 Million - $8.67 Million
-87,700 Reduced 29.11%
213,600 $20.2 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $107,736 - $127,476
-1,200 Reduced 0.4%
301,300 $27.9 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $35.5 Million - $47.6 Million
-386,000 Reduced 56.06%
302,500 $28.6 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $35.3 Million - $38.7 Million
394,400 Added 134.1%
688,500 $66.6 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $20.5 Million - $26.2 Million
294,100
294,100 $26.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.